EnvoyHealth Becomes Optum Frontier Therapies
Dec 2, 2020
In November of 2020 Optum introduced Optum Frontier Therapies, a new pharmacy services business with a mission to support people with compassion, while creating access to therapies at the frontier of health care—including rare disease drugs, gene and other advanced therapies, and digital therapeutics. These therapies all raise unique challenges and require custom models to support supply chain handling, holistic patient services, innovative payer agreements, advanced data and analytics, and digitally enabled operations to simplify a complex ecosystem.
Earlier this year, EnvoyHealth joined the Optum family through the acquisition of Diplomat, Inc. We are pleased to share that beginning in December 2020 EnvoyHealth will become part of Optum Frontier Therapies. Envoy’s expertise in managing custom pharmacy models for digital therapeutics, operating noncommercial pharmacy programs, and distributing specialty drugs will amplify the capabilities of Optum Frontier Therapies.
The EnvoyHealth team is thrilled to join this new business. Over the coming months, EnvoyHealth will be fully integrated into Optum Frontier Therapies. We are excited to draw upon our core competencies while continuing to serve our partners who are redefining the health care landscape.
For more information about Optum Frontier Therapies, please visit frontiertherapies.optum.com.
